Format

Send to

Choose Destination
Praxis (Bern 1994). 2019 Jun;108(8):541-553. doi: 10.1024/1661-8157/a003246.

[Ketogenic Diet and its Evidence-Based Therapeutic Implementation in Endocrine Diseases].

[Article in German; Abstract available in German from the publisher]

Author information

1
1 Universitätsklinik für Diabetologie, Endokrinologie, Ernährungsmedizin & Metabolismus (UDEM), Inselspital Bern.
2
2 Zentrum für Labormedizin, Inselspital Bern.

Abstract

in English, German

Ketogenic Diet and its Evidence-Based Therapeutic Implementation in Endocrine Diseases Abstract. Abstract: The ketogenic diet (KD) is a high-fat and very low-carb diet, which has been used primarily for treatment of therapy-resistant epilepsy in children. Implementation of the KD in other target populations is increasingly being discussed. This literature review provides first indications for a clinical benefit of the KD in diabetes mellitus type 2 (T2DM) and polycystic ovarian syndrome (PCOS). In many analysed studies, KD led to significant weight loss and had beneficial effects on lipoprotein profile and insulin resistance. In half of the comparative studies with T2DM, the KD lead to signifiantly greater reductions in HbA1c-levels (HbA1c difference: -0.5 to -1.5 %) compared to reference diets (HbA1c difference: +0.2 to -0.5 %). Nevertheless, study results are too heterogenic for a general recommendation of the KD in this patient population.

KEYWORDS:

Diabetes mellitus Typ 2; Ketogene Diät; Ketogenic diet; Régime cétogène; diabète mellitus type 2; polycystic ovary syndrome (PCOS); polyzystisches Ovarialsyndrom (PCOS); syndrome des ovaires; type 2 diabetes mellitus

PMID:
31185843
DOI:
10.1024/1661-8157/a003246
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center